Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 28

1.

Large-scale proteomics analysis of human ovarian cancer for biomarkers.

Bengtsson S, Krogh M, Szigyarto CA, Uhlen M, Schedvins K, Silfverswärd C, Linder S, Auer G, Alaiya A, James P.

J Proteome Res. 2007 Apr;6(4):1440-50. Epub 2007 Feb 22.

PMID:
17315909
2.

Application of proteomics in ovarian cancer: which sample should be used?

Cadron I, Van Gorp T, Timmerman D, Amant F, Waelkens E, Vergote I.

Gynecol Oncol. 2009 Dec;115(3):497-503. doi: 10.1016/j.ygyno.2009.09.005. Epub 2009 Oct 6. Review.

PMID:
19811810
3.

Proteins' promise--progress and challenges in ovarian cancer proteomics.

Koehn H, Oehler MK.

Menopause Int. 2007 Dec;13(4):148-53. Review.

PMID:
18088525
4.

Applying proteomics in clinical trials: assessing the potential and practical limitations in ovarian cancer.

Tchabo NE, Liel MS, Kohn EC.

Am J Pharmacogenomics. 2005;5(3):141-8. Review.

PMID:
15952868
5.

Discovery and application of protein biomarkers for ovarian cancer.

Gagnon A, Ye B.

Curr Opin Obstet Gynecol. 2008 Feb;20(1):9-13. doi: 10.1097/GCO.0b013e3282f226a5. Review.

PMID:
18196999
6.

Serum and tissue biomarkers as predictive and prognostic variables in epithelial ovarian cancer.

Gadducci A, Cosio S, Tana R, Genazzani AR.

Crit Rev Oncol Hematol. 2009 Jan;69(1):12-27. doi: 10.1016/j.critrevonc.2008.05.001. Epub 2008 Jul 1. Review.

PMID:
18595727
7.

Proteomics in cancer.

Reymond MA, Schlegel W.

Adv Clin Chem. 2007;44:103-42. Review.

PMID:
17682341
8.

Biologic prognostic factors in ovarian cancer: a review.

Framarino dei Malatesta ML, Veneziano M, Peppicelli M, Lanzi G, Marzetti L.

Eur J Gynaecol Oncol. 1998;19(2):123-5. Review.

PMID:
9611049
9.

Conventional and proteomic technologies for the detection of early stage malignancies: markers for ovarian cancer.

Lee CJ, Ariztia EV, Fishman DA.

Crit Rev Clin Lab Sci. 2007;44(1):87-114. Review.

PMID:
17175521
10.

[Identification of new ovarian cancer biomarkers with proteomic analyses--the diagnostic tool of the future?].

Petri AL, Høgdall E, Engelholm SA, Christensen IJ, Kjaer SK, Høgdall CK.

Ugeskr Laeger. 2007 Aug 13;169(33):2614-9. Review. Danish.

PMID:
17725906
11.

[Molecular profiling and predictive signatures. Biomarker analysis in ovarian cancer].

Denkert C.

Pathologe. 2008 Nov;29 Suppl 2:168-71. doi: 10.1007/s00292-008-1073-4. Review. German.

PMID:
18931999
12.

Anti-tumor antibodies in ovarian cancer.

Luborsky JL, Barua A, Shatavi SV, Kebede T, Abramowicz J, Rotmensch J.

Am J Reprod Immunol. 2005 Aug;54(2):55-62. Review.

PMID:
16105096
13.

Early diagnosis and predictors of malignancy of adnexal masses.

Murta EF, Nomelini RS.

Curr Opin Obstet Gynecol. 2006 Feb;18(1):14-9. Review.

PMID:
16493254
14.

Proteomics and biomarkers for ovarian cancer diagnosis.

Zhang B, Barekati Z, Kohler C, Radpour R, Asadollahi R, Holzgreve W, Zhong XY.

Ann Clin Lab Sci. 2010 Summer;40(3):218-25. Review.

PMID:
20689132
15.

Advances in ovarian cancer proteomics: the quest for biomarkers and improved therapeutic interventions.

Jurisicova A, Jurisica I, Kislinger T.

Expert Rev Proteomics. 2008 Aug;5(4):551-60. doi: 10.1586/14789450.5.4.551. Review.

PMID:
18761466
16.

Recent technical strategies to identify diagnostic biomarkers for ovarian cancer.

Ye B, Gagnon A, Mok SC.

Expert Rev Proteomics. 2007 Feb;4(1):121-31. Review.

PMID:
17288520
17.

The footprints of cancer development: Cancer biomarkers.

Ullah MF, Aatif M.

Cancer Treat Rev. 2009 May;35(3):193-200. doi: 10.1016/j.ctrv.2008.10.004. Epub 2008 Dec 4. Review.

PMID:
19062197
18.

An overview of biomarkers for the ovarian cancer diagnosis.

Zhang B, Cai FF, Zhong XY.

Eur J Obstet Gynecol Reprod Biol. 2011 Oct;158(2):119-23. doi: 10.1016/j.ejogrb.2011.04.023. Epub 2011 May 31. Review.

PMID:
21632171
19.

[Screening methods for malignant ovarian tumors in adult women].

Milenković V, Sparić R, Atanacković J.

Srp Arh Celok Lek. 2005 Jan-Feb;133(1-2):72-5. Review. Serbian.

20.

Status of tumor markers in epithelial ovarian cancer has there been any progress? A review.

Husseinzadeh N.

Gynecol Oncol. 2011 Jan;120(1):152-7. doi: 10.1016/j.ygyno.2010.09.002. Epub 2010 Oct 14. Review.

PMID:
20934205

Supplemental Content

Support Center